Recent developments in receptor tyrosine kinase inhibitors: A promising mainstay in targeted cancer therapy
-
Published:2024-09
Issue:
Volume:23
Page:100195
-
ISSN:2590-0986
-
Container-title:Medicine in Drug Discovery
-
language:en
-
Short-container-title:Medicine in Drug Discovery
Author:
Kumar Rahul,
Goel Harsh,
Solanki Raghu,
Rawat Laxminarayan,
Tabasum Saba,
Tanwar Pranay,
Pal Soumitro,
Sabarwal AkashORCID
Reference100 articles.
1. Ferlay J, Colombet M, Soerjomataram I, Parkin DM, Piñeros M, Znaor A, Bray F. Cancer statistics for the year 2020: An overview. Int J Cancer. 2021 Apr 5. doi: 10.1002/ijc.33588. Epub ahead of print. PMID: 33818764.
2. Siegel, R. L., Giaquinto, A. N., & Jemal, A. (2024). Cancer statistics, 2024. CA: a cancer journal for clinicians. 2024 Jan 17. doi:10.3322/caac.21820.
3. A subcellular map of the human kinome;Zhang;Elife,2021
4. Karve TM, Cheema AK. Small changes huge impact: the role of protein posttranslational modifications in cellular homeostasis and disease. J Amino Acids. 2011;2011:207691. doi: 10.4061/2011/207691. Epub 2011 Jul 21. PMID: 22312457; PMCID: PMC3268018.
5. Akt signalling in health and disease;Hers;Cell Signal,2011